Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02934451 · ClinicalTrials.gov registry record
Dental Malocclusion and Craniofacial Development in OI
A clinical trial of Osteogenesis Imperfecta, sponsored by Baylor College of Medicine.
- Active
- Registry status
- 75
- Enrollment target
- 3
- Study locations
NCT02934451 is a study of Osteogenesis Imperfecta that is active but no longer recruiting, run by Baylor College of Medicine. The registered enrollment target is 75 participants, below the 155-participant average among 13 other Osteogenesis Imperfecta trials with a reported enrollment target (52% lower). The trial reports 3 study locations across 3 states.
The verdict
NCT02934451, a study of Osteogenesis Imperfecta, is active but no longer recruiting, sponsored by Baylor College of Medicine.
- ACTIVE NOT RECRUITING
- Registry status
- 75 participants
- Enrollment target
- 3
- Study locations
Study Summary
Osteogenesis imperfecta (OI) is a rare inherited disorder that causes bones to break easily. Individuals with osteogenesis imperfecta break bones often and may have other problems, including hearing loss and pain and difficulty getting around. People with moderate to severe OI may also be diagnosed with dentinogenesis imperfecta (DI). DI is characterized by grey or brown teeth that may chip and wear down and break easily. People with DI may also have skull and neck defects. These patients may have severe teeth misalignment resulting in clinically significant chewing problems. Teeth misalignment in OI is very hard to treat because of the quality and quantity of bone. The overall goal of this study is to improve dental health to improve the quality of life of people with OI.
Conditions Studied
Study Locations (3)
California
- University of California Los Angeles - Los Angeles
Texas
- Baylor College of Medicine - Houston
Quebec
- Shriners Hospital for Children - Montreal
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2016-08 |
| Est. Completion | 2027-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02934451
The ClinicalTrials.gov registry entry for NCT02934451 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 155-participant average among 13 other Osteogenesis Imperfecta trials with a reported enrollment target (52% lower). The listed sponsor is Baylor College of Medicine, which has 616 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Osteogenesis Imperfecta appearing as the primary indexed condition, and to 0 interventions.
NCT02934451 reports 3 study locations spanning 3 distinct geographic areas - top geographies include California, Texas, Quebec.
Frequently Asked Questions
What is clinical trial NCT02934451 about?
NCT02934451 is a clinical study titled "Dental Malocclusion and Craniofacial Development in OI". Osteogenesis imperfecta (OI) is a rare inherited disorder that causes bones to break easily. Individuals with osteogenesis imperfecta break bones often and may have other problems, including hearing loss and pain and difficulty getting around. People with moderate to severe OI may also be diagnosed ...
What is the current status of trial NCT02934451?
This trial is currently active not recruiting. The enrollment target is 75 participants. The study started on 2016-08. Estimated completion is 2027-12.
What conditions does trial NCT02934451 study?
This clinical trial studies the following conditions: Osteogenesis Imperfecta.
Who is sponsoring clinical trial NCT02934451?
This trial is sponsored by Baylor College of Medicine, which has 616 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02934451 being conducted?
This trial has 3 study locations across California, Texas, Quebec. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Osteogenesis Imperfecta
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Study to Evaluate Efficacy and Safety of Romosozumab Compared With Bisphosphonates in Children and Adolescents With Osteogenesis Imperfecta
RECRUITING · Phase 3
-
Effects of Bisphosphonates on OI-Related Hearing Loss
RECRUITING · Phase 4
-
BBD Longitudinal Study of Osteogenesis Imperfecta
RECRUITING
-
Setrusumab vs Placebo for Osteogenesis Imperfecta
ACTIVE NOT RECRUITING · Phase 2
-
Urinary Biomarkers of OI Pathobiology
ACTIVE NOT RECRUITING
-
Clear Aligners for the Treatment of Dental Malocclusion in OI
ACTIVE NOT RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.